head-and-neck-cancer

Documents about head-and-neck-cancer

• Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer#908420ClinicalTrials.gov
• A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors#806826ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors#837331ClinicalTrials.gov
• GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma#870624ClinicalTrials.gov
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors#825504ClinicalTrials.gov
• AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer#813112ClinicalTrials.gov
• Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer#873612ClinicalTrials.gov
• Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer#887818ClinicalTrials.gov
• Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck#303591ClinicalTrials.gov
• A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549#905067ClinicalTrials.gov
• Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer#853243ClinicalTrials.gov
• Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck#892819ClinicalTrials.gov
• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma#827716ClinicalTrials.gov
• Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery#993585ClinicalTrials.gov
• Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer#896335ClinicalTrials.gov
• Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer#905159ClinicalTrials.gov
• Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer#912914ClinicalTrials.gov
• Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery#881524ClinicalTrials.gov
• FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)#882957ClinicalTrials.gov
• Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery#966154ClinicalTrials.gov
• Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach#983593eScholarship
• A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors#826788ClinicalTrials.gov
• Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer#875036ClinicalTrials.gov
• EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer#838260ClinicalTrials.gov
• Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)#914247ClinicalTrials.gov
• External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC#856971ClinicalTrials.gov
• Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck#852967ClinicalTrials.gov
• Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer#966165ClinicalTrials.gov
• Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital#917051ClinicalTrials.gov
• Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck#875418ClinicalTrials.gov
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer#982457ClinicalTrials.gov
• Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck#914942ClinicalTrials.gov
• First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor#876970ClinicalTrials.gov
• Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)#1010586ClinicalTrials.gov
• Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck#873306ClinicalTrials.gov
• European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]#878851ClinicalTrials.gov
• Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer#1047633ClinicalTrials.gov
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx#1010347ClinicalTrials.gov
• Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy#905193ClinicalTrials.gov
• Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma#803913ClinicalTrials.gov
• Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin#883387ClinicalTrials.gov